Drawing for MIDAS

USPTO serial 76356771

MIDAS

Reviewed by CopyMark Law Group

Reg. 2829082Status 800Registered
Filing date
Status date
Registration date
Apr 6, 2004
Examiner
MCMORROW, RONALD G
Law office
GENERIC WEB UPDATE

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with MIDAS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Max Moskowitz

Max Moskowitz Ostrolenk Faber LLP845 THIRD AVENUE, 17th FloorNew York, NY 10022UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001chemicals used in the manufacture of pharmaceutical preparationsACTIVE—
003[ cosmetics not including sun screens, sun tanning products nor accessories used in connection with cosmetics ]SECTION 8 - CANCELLED—
005[ pharmaceutical preparations for the alimentary tract and metabolism, for blood and blood forming organs, for the cardiovascular system, for the musculoskeletal system, for the central nervous system, for the peripheral nervous system, for the genitourinary system, for the respiratory system, for treating dermatological disorders, hormones for medical purposes, anti-infective and anti-viral preparations, cytostatic preparations, allergy medication, nutrient dietary preparations adapted for medical purposes, dietary supplements, foods for medically restricted diets and active ingredients sold as integral components of pharmaceutical preparations for use in the treatment of the foregoing conditions, not including pesticides, insecticides, herbicides and fungicides ]SECTION 8 - CANCELLED—
035licensing of pharmaceutical preparations [ and cosmetics not including sun screens, suntanning products or accessories used in connection with cosmetics ] and business marketing consultation services with respect to the sale of marketing authorizations for pharmaceutical preparations [ and cosmetics not including sun screens, suntanning products nor accessories used in connection with cosmetics ]ACTIVE—
036[ business brokerage services and business finance procumbent services for product and company acquisitions ]SECTION 8 - CANCELLED—
040[ manufacture of pharmaceutical preparations not including pesticides, insecticides, herbicides and fungicides and manufacture of cosmetics, not including sun screens and sun tanning products, to the order and specification of others ]SECTION 8 - CANCELLED—
042legal representation of third parties in the development, preparation and sale of registration dossiers in respect of pharmaceutical preparations *; * [and cosmetics not including sun screens, suntanning products nor accessories used in connection with cosmetics; ] legal representation of third parties in pursuing and prosecuting registration procedures in respect of pharmaceutical preparations [ and cosmetics not including sun screens, suntanning products nor accessories used in connection with cosmetics, ] and product development consultation for the pharmaceutical [ and cosmetic ] industry, namely, consultation with respect to custom synthesis of new chemical compounds for use in the manufacture of pharmaceutical preparations [ and cosmetics not including sun screens, suntanning products or accessories used in connection with cosmetics ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 9, 2024NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Feb 9, 2024RNL2REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Feb 9, 202489AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Feb 8, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 13, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 15, 2023E89RTEAS SECTION 8 & 9 RECEIVED—
Apr 6, 2023REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Oct 11, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 19, 2014NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Apr 19, 2014RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Apr 19, 201489AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Apr 18, 2014APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 3, 201489AFREGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED—
Apr 3, 2014E89RTEAS SECTION 8 & 9 RECEIVED—
Sep 30, 2010CORVREVIEW OF CORRESPONDENCE COMPLETE—
Sep 3, 2010MAILPAPER RECEIVED—
May 22, 2010C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
May 19, 2010APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 29, 2010815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED—
Mar 29, 2010MAILPAPER RECEIVED—
May 25, 2007CFITCASE FILE IN TICRS—
Apr 6, 2004R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 14, 2003ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 14, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 24, 2003NPUBNOTICE OF PUBLICATION—
Jul 29, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 22, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 22, 2003MAILPAPER RECEIVED—
Apr 10, 2003CNCFCONTINUATION OF FINAL REFUSAL MAILED—
Feb 3, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 3, 2003MAILPAPER RECEIVED—
Nov 21, 2002CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 7, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 7, 2002MAILPAPER RECEIVED—
Sep 27, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 27, 2002MAILPAPER RECEIVED—
Apr 11, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 28, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance